Cited by 3,114T-cell and B-cell ImmunologyCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.

Molecular mechanisms of T cell co-stimulation and co-inhibition

Open access

Chen, Lieping, Flies, Dallas B.·2013·Nature Reviews Immunology

Open this paper in CoChat — free account

Abstract

Co-stimulatory and co-inhibitory receptors have a pivotal role in T cell biology, as they determine the functional outcome of T cell receptor (TCR) signalling. The classic definition of T cell co-stimulation continues to evolve through the identification of new co-stimulatory and co-inhibitory receptors, the biochemical characterization of their downstream signalling events and the delineation of their immunological functions. Notably, it has been recently appreciated that co-stimulatory and co-inhibitory receptors display great diversity in expression, structure and function, and that their functions are largely context dependent. Here, we focus on some of these emerging concepts and review the mechanisms through which T cell activation, differentiation and function is controlled by co-stimulatory and co-inhibitory receptors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nri3405

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Self-citation
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
T cell exhaustion
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
The B7 family revisited
Greenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,072
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4
Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., et al. (2011) · Science · doi:10.1126/science.1202947 · Cited by 1,860

Flagged first, then by citations

Show all 135 references

Research works printed but not linked: 1

Lafferty, K. J. & Cunningham, A. J. A. New analysis of allogeneic interactions. J. Immunol. 112, 436–437 (1975). Lafferty and Cunningham extended the Bretscher and Cohn two-signal model to suggest that T cells require two signals for activation.

Sorted by citations

Items 901–1,000 of 1,003

Molecular Insights for Optimizing T Cell Receptor Specificity Against Cancer
Hebeisen, M., Oberle, S. G., Presotto, D., Speiser, D. E., Zehn, D., & Rufer, N. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00154 · Cited by 39
MicroRNA-21 deficiency protects from lupus-like autoimmunity in the chronic graft-versus-host disease model of systemic lupus erythematosus
Garchow, B. G., & Kiriakidou, M. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.11.010 · Cited by 38
Taking up Cancer Immunotherapy Challenges: Bispecific Antibodies, the Path Forward?
del Bano, J., Chames, P., Baty, D., & Kerfélec, B. (2015) · Antibodies · doi:10.3390/antib5010001 · Cited by 39
Nectin spot: a novel type of nectin-mediated cell adhesion apparatus
Mizutani, K., & Takai, Y. (2016) · Biochemical Journal · doi:10.1042/bcj20160235 · Cited by 38
ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell Responses
Hecht, I., Toporik, A., Podojil, J. R., Vaknin, I., Cojocaru, G., Oren, A., Aizman, E., Liang, S. C., Leung, L., Dicken, Y., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700325 · Cited by 38
CD80/CD86 signaling contributes to the proinflammatory response of Staphylococcus aureus in the airway
Parker, D. (2018) · Cytokine · doi:10.1016/j.cyto.2018.01.016 · Cited by 38
Aberrant T cell subsets and cytokines expression profile in systemic lupus erythematosus
Zhou, H., Hu, B., Huang, N., Mo, X., Li, W., Zhang, B., Wei, B., Gao, M., Wang, Y., Liu, X., et al. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4124-0 · Cited by 39
Targeting the tumor microenvironment to overcome immune checkpoint blockade therapy resistance
Li, Y., Liu, J., Gao, L., Liu, Y., Meng, F., Li, X., & Qin, F. X.-F. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.03.006 · Cited by 39
Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease
Thangavelu, G., & Blazar, B. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00309 · Cited by 37
Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors
Lai, B., Wang, J., Fagenson, A. M., Sun, Y., Saredy, J., Lu, Y., Nanayakkara, G., Yang, W. Y., Yu, D., Shao, Y., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02612 · Cited by 37
The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers
Kooshkaki, O., Derakhshani, A., Safarpour, H., Najafi, S., Vahedi, P., Brunetti, O., Torabi, M., Lotfinejad, P., Paradiso, A., Racanelli, V., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145034 · Cited by 38
Frequent Low-Dose Δ9-Tetrahydrocannabinol in Adolescence Disrupts Microglia Homeostasis and Disables Responses to Microbial Infection and Social Stress in Young Adulthood
Lee, H.-L., Jung, K.-M., Fotio, Y., Squire, E., Palese, F., Lin, L., Torrens, A., Ahmed, F., Mabou Tagne, A., Ramirez, J., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.04.017 · Cited by 38
CD28 family of receptors on T cells in chronic HBV infection: Expression characteristics, clinical significance and correlations with PD-1 blockade
Tang, Z., Hao, Y.-H., Zhang, E., Xu, C., Zhou, Y., Zheng, X., & Yang, D. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5396 · Cited by 39
Effect of cryopreservation on delineation of immune cell subpopulations in tumor specimens as determined by multiparametric single cell mass cytometry analysis
Kadić, E., Moniz, R. J., Huo, Y., Chi, A., & Kariv, I. (2017) · BMC Immunology · doi:10.1186/s12865-017-0192-1 · Cited by 37
Rapamycin Prevents Surgery-Induced Immune Dysfunction in Patients with Bladder Cancer
Svatek, R. S., Ji, N., Leon, E. D., Mukherjee, N. Z., Kabra, A. T., Hurez, V. J., Nicolas, M. M., Michalek, J. E., Javors, M. A., Wheeler, K. M., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0336 · Cited by 38
Multiscale network analysis reveals molecular mechanisms and key regulators of the tumor microenvironment in gastric cancer
Song, W., Lin, X., Liao, X., Hu, D., Lin, J., Sarpel, U., Ye, Y., Feferman, Y., Labow, D. M., Walsh, M. J., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32643 · Cited by 36
T-cell senescence: A crucial player in autoimmune diseases
Lu, Y., Ruan, Y., Pan, H., Rui, K., Liu, Q., Wang, S., & Cui, D. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109202 · Cited by 41
Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy
Sadeghirad, H., Liu, N., Monkman, J. H., Ma, N., Cheikh, B. B., Jhaveri, N., Tan, C. W., Warkiani, M. E., Adams, M. N., Nguyen, Q. H., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1135489 · Cited by 35
“Co-stimulatory molecules, such as CD40 or 4-1BB, have positive impact on immune cell functions, but co-inhibitory molecules, such as PD-1/PD-L1 or CTLA-4, have the opposite effect (49, 50).”
Background
Fish oil-based microemulsion can efficiently deliver oral peptide blocking PD-1/PD-L1 and simultaneously induce ferroptosis for cancer immunotherapy
Yang, X., Li, W., Li, S., Chen, S., Hu, Z., He, Z., Zhu, X., Niu, X., Zhou, X., Li, H., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.042 · Cited by 37
Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective
Liu, D., Liu, L., Li, X., Wang, S., Wu, G., & Che, X. (2024) · Vaccines · doi:10.3390/vaccines12080950 · Cited by 40
“T-cell T-cell activation involves the interaction between the T-cell receptor (TCR) on the T cell and the peptide–MHC complex on the APC, along with necessary co-stimulatory signals [102,103].”
Background
An OMV‐Based Nanovaccine as Antigen Presentation Signal Enhancer for Cancer Immunotherapy
Lu, Y., Ma, N., Cheng, K., Liu, G., Liang, J., Chen, X., Li, D., Cao, C., Gao, X., Chen, L., et al. (2025) · Advanced Materials · doi:10.1002/adma.202413392 · Cited by 39
Self-citation
CD70 Is Downregulated by Interaction with CD27
Kuka, M., Munitić, I., Torchia, M. L. G., & Ashwell, J. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300868 · Cited by 37
STAT3 and NF-κB are Simultaneously Suppressed in Dendritic Cells in Lung Cancer
Li, R., Fang, F., Jiang, M., Wang, C., Ma, J., Kang, W., Zhang, Q., Miao, Y., Wang, D., Guo, Y., et al. (2017) · Scientific Reports · doi:10.1038/srep45395 · Cited by 37
Label-free Analysis of CD8+ T Cell Subset Proteomes Supports a Progressive Differentiation Model of Human-Virus-Specific T Cells
van Aalderen, M. C., van den Biggelaar, M., Remmerswaal, E. B. M., van Alphen, F. P. J., Meijer, A. B., ten Berge, I. J. M., & van Lier, R. A. W. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.014 · Cited by 38
Targeting the programmed cell death-1 pathway in rheumatoid arthritis
Sandigursky, S., Silverman, G. J., & Mor, A. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.05.025 · Cited by 38
SOCS1: Regulator of T Cells in Autoimmunity and Cancer
Ilangumaran, S., Bobbala, D., & Ramanathan, S. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_63 · Cited by 37
The role of immune regulatory molecules in multiple sclerosis
Afshar, B., Khalifehzadeh-Esfahani, Z., Seyfizadeh, N., Danbaran, G. R., Hemmatzadeh, M., & Mohammadi, H. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577061 · Cited by 38
A Quantitative Multivariate Model of Human Dendritic Cell-T Helper Cell Communication
Grandclaudon, M., Perrot-Dockès, M., Trichot, C., Karpf, L., Abouzid, O., Chauvin, C., Sirven, P., Abou-Jaoudé, W., Berger, F., Hupé, P., et al. (2019) · Cell · doi:10.1016/j.cell.2019.09.012 · Cited by 37
Targeting T Cell Activation in Immuno-Oncology
Saibil, S. D., & Ohashi, P. S. (2020) · Current Oncology · doi:10.3747/co.27.5285 · Cited by 39
CD137 / CD137 ligand signalling regulates the immune balance: A potential target for novel immunotherapy of autoimmune diseases
Wong, H. Y., & Schwarz, H. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102499 · Cited by 37
CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti–PD-L1 Treatment
Volpin, V., Michels, T., Sorrentino, A., Menevse, A. N., Knoll, G., Ditz, M., Milenkovic, V. M., Chen, C.-Y., Rathinasamy, A., Griewank, K., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0608 · Cited by 38
Contributions of T cells in multiple sclerosis: what do we currently know?
Arneth, B. M. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10275-x · Cited by 36
4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2nd Generation Chimeric Antigen Receptor-Modified T Cells
Dai, Q. G., Han, P., Qi, X., Li, F., Li, M., Fan, L., Zhang, H., Zhang, X., & Yang, X. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.539654 · Cited by 40
Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control
Quixabeira, D. C. A., Zafar, S., Santos, J. M., Cervera-Carrascón, V., Havunen, R., Kudling, T. V., Basnet, S., Anttila, M. O., Kanerva, A., & Hemminki, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.674400 · Cited by 37
Facile Transformation of Murine and Human Primary Dendritic Cells into Robust and Modular Artificial Antigen‐Presenting Systems by Intracellular Hydrogelation
Lin, J., Hsu, C., Chen, J., Fang, Z., Chen, H., Yao, B., Shiau, G. H. M., Tsai, J., Gu, M., Jung, M., et al. (2021) · Advanced Materials · doi:10.1002/adma.202101190 · Cited by 37
Inherited human c-Rel deficiency disrupts myeloid and lymphoid immunity to multiple infectious agents
Lévy, R., Langlais, D., Béziat, V., Rapaport, F., Rao, G., Lazarov, T., Bourgey, M., Zhou, Y., Briand, C., Moriya, K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci150143 · Cited by 41
Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome
Lee, P., Yim, R., Yung, Y., Chu, H.-T., Yip, P.-K., & Gill, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910232 · Cited by 40
Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications
Cabo, M., Offringa, R., Zitvogel, L., Kroemer, G., Muntasell, A., & Galluzzi, L. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1371896 · Cited by 37
Cell‐Based Drug Delivery Systems Participate in the Cancer Immunity Cycle for Improved Cancer Immunotherapy
Fan, X., Wang, K., Qi, L., Lu, Y., & Sun, J. (2022) · Small · doi:10.1002/smll.202205166 · Cited by 37
Protein Footprinting and X-ray Crystallography Reveal the Interaction of PD-L1 and a Macrocyclic Peptide
Niu, B., Appleby, T. C., Wang, R., Morar, M., Voight, J., Villaseñor, A. G., Clancy, S., Wise, S. J., Belzile, J.-P., Papalia, G. A., et al. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00822 · Cited by 37
Function and evolution of the prototypic CD28ζ and 4-1BBζ chimeric antigen receptors
Feucht, J., & Sadelain, M. (2020) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2020.09.001 · Cited by 42
Immune Editing: Overcoming Immune Barriers in Stem Cell Transplantation
Meissner, T. B., Schulze, H. S., & Dale, S. M. (2022) · Current Stem Cell Reports · doi:10.1007/s40778-022-00221-0 · Cited by 39
Complexities in comparing the impact of costimulatory domains on approved CD19 CAR functionality
Smith, R. M., & Shen, R. R. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04372-4 · Cited by 40
Site-specific regulation of Th2 differentiation within lymph node microenvironments
Lyons‐Cohen, M. R., Shamskhou, E. A., & Gerner, M. Y. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231282 · Cited by 37
“…the production of IL-2 by activated T cells, as well as can elicit the production of the Th2 cytokine IL-4 in vitro (Acuto and Michel, 2003; Bhattacharyya and Feng, 2020; Chen and Flies, 2013; Gause et al., 1997; King et al., 1995; Rulifson et al., 1997; Tao et al., 1997; van Rijt et al., 2004).”
Background
TLR5 Ligand–Secreting T Cells Reshape the Tumor Microenvironment and Enhance Antitumor Activity
Geng, D., Kaczanowska, S., Tsai, A., Younger, K., Ochoa, A. C., Rapoport, A. P., Ostrand-Rosenberg, S., & Dávila, E. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2467 · Cited by 36
Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy
Subhash, V. V., Yeo, M. S., Tan, W. L., & Yong, W. P. (2015) · Journal of Immunology Research · doi:10.1155/2015/308574 · Cited by 36
Intrinsic and Tumor Microenvironment-Induced Metabolism Adaptations of T Cells and Impact on Their Differentiation and Function
Kouidhi, S., Noman, M. Z., Kiéda, C., Elgaaïed, A. B., & Chouaïb, S. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00114 · Cited by 39
CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T Cells
Velasquez, M. P., Szöőr, Á., Vaidya, A. B., Thakkar, A., Nguyen, P., Wu, M., Liu, H., & Gottschalk, S. M. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0171 · Cited by 37
Distinct Changes of BTLA and HVEM Expressions in Circulating CD4+ and CD8+ T Cells in Hepatocellular Carcinoma Patients
Liu, J., Li, J., He, M. Y., Zhang, G.-L., & Zhao, Q. (2018) · Journal of Immunology Research · doi:10.1155/2018/4561571 · Cited by 38
Preclinical characterization of Sintilimab, a fully human anti-PD-1 therapeutic monoclonal antibody for cancer
Zhang, S., Zhang, M., Wu, W., Yuan, Z., Tsun, A., Wu, M. H., Chen, B., Jia, L., Miao, X., Miao, X., et al. (2018) · Antibody Therapeutics · doi:10.1093/abt/tby005 · Cited by 36
Therapeutic and Diagnostic Implications of T Cell Scarring in Celiac Disease and Beyond
Christophersen, A. O., Risnes, L. F., Dahal‐Koirala, S., & Sollid, L. M. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.05.009 · Cited by 36
Genomics and Therapeutic Vulnerabilities of Primary Bone Tumors
Scotlandi, K., Hattinger, C. M., Pellegrini, E., Gambarotti, M., & Serra, M. (2020) · Cells · doi:10.3390/cells9040968 · Cited by 41
Effectiveness of PD-1/PD-L1 inhibitors in the treatment of lung cancer: Brightness and challenge
Yang, Y., Yu, Y., & Lü, S. (2020) · Science China Life Sciences · doi:10.1007/s11427-019-1622-5 · Cited by 37
Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy
Amon, L., Hatscher, L., Heger, L., Dudziak, D., & Lehmann, C. H. K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070663 · Cited by 37
Impact of Local Alloimmunity and Recipient Cells in Transplant Arteriosclerosis
Cai, J., Deng, J., Gu, W., Ni, Z., Liu, Y., Kamra, Y., Saxena, A., Hu, Y., Yuan, H., Xiao, Q., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.316470 · Cited by 36
Pig conceptuses secrete interferon gamma to recruit T cells to the endometrium during the peri-implantation period
McLendon, B. A., Seo, H., Kramer, A. C., Burghardt, R. C., Bazer, F. W., & Johnson, G. A. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa132 · Cited by 36
Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development
Kiaie, S. H., Sanaei, M., Heshmati, M., Asadzadeh, Z., Azimi, I., Hadidi, S., Jafari, R., & Baradaran, B. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.12.011 · Cited by 37
Guillain‐Barré Syndrome‐Like Polyneuropathy Associated with Immune Checkpoint Inhibitors: A Systematic Review of 33 Cases
Li, Y., Zhang, X., & Zhao, C. (2021) · BioMed Research International · doi:10.1155/2021/9800488 · Cited by 36
The ABCs of Antigen Presentation by Stromal Non-Professional Antigen-Presenting Cells
Harryvan, T. J., de Lange, S., Hawinkels, L. J. A. C., & Verdegaal, E. M. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010137 · Cited by 39
The Interplay between PARP Inhibitors and Immunotherapy in Ovarian Cancer: The Rationale behind a New Combination Therapy
Maiorano, B. A., Lorusso, D., Maiorano, M. F. P., Ciardiello, D., Parrella, P., Petracca, A., Cormio, G., & Maiello, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073871 · Cited by 39
“Antigen-presenting cells (APCs) activate T-cells after presenting antigens bound to major histocompatibility complex (MHC) to T-cell receptor (TCR), together with co-stimulatory signals developing after cluster of differentiation (CD)-80/B7-1 and CD86/B7-2 on APCs bind CD28 located on T-cells.”
BackgroundInfluential
T cell responses to control fungal infection in an immunological memory lens
Sharma, J., Mudalagiriyappa, S., & Nanjappa, S. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.905867 · Cited by 39
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells
Amaro, A. A., Reggiani, F., Fenoglio, D., Gangemi, R. M. R., Tosi, A., Parodi, A., Banelli, B., Rigo, V., Mastracci, L., Grillo, F., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02628-x · Cited by 35
“In order to be effective, epigenetic therapy is expected to exert several of the following functions: 1) to recover/ induce tumor neo-antigens presentation [10]; 2) to favor recruitment of antigen–specific cytotoxic CD8+ T cells into the tumor microenvironment (TME) [11, 12]; 3) to restore activating co-stimulatory mo…”
Background
Novel Approaches to Enhance the Specificity and Safety of Engineered T Cells
Fedorov, V. D., Sadelain, M., & Kloss, C. C. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000040 · Cited by 35
Genome-wide search followed by replication reveals genetic interaction of CD80 and ALOX5AP associated with systemic lupus erythematosus in Asian populations
Zhang, Y., Yang, J., Zhang, J., Sun, L., Hirankarn, N., Pan, H., Lau, C. S., Chan, T. M., Lee, T. L., Leung, A. M. H., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206367 · Cited by 34
Leveraging immunotherapy for the treatment of gynecologic cancers in the era of precision medicine
Zamarin, D., & Jazaeri, A. A. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.12.030 · Cited by 35
The HIV-1 accessory proteins Nef and Vpu downregulate total and cell surface CD28 in CD4+ T cells
Pawlak, E. N., Dirk, B. S., Jacob, R. A., Johnson, A. L., & Dikeakos, J. D. (2018) · Retrovirology · doi:10.1186/s12977-018-0388-3 · Cited by 37
PD-1/PD-L1 inhibitor screening of caffeoylquinic acid compounds using surface plasmon resonance spectroscopy
Han, Y., Gao, Y., Tian, H., Wang, D., Guo, N., Zhang, X., Chen, S., & Wang, H. (2018) · Analytical Biochemistry · doi:10.1016/j.ab.2018.02.003 · Cited by 35
Translation of cancer immunotherapy from the bench to the bedside
Guo, Q., Huang, F., Gonçalves, C., Rincon, S. V. D., & Miller, W. H. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.001 · Cited by 35
Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions
Yoshida, N., Shigemori, K., Donaldson, N. L., Trevisani, C. P., Cordero, N. A., Stevenson, K. E., Bu, X., Arakawa, F., Takeuchi, M., Ohshima, K., et al. (2020) · Blood · doi:10.1182/blood.2019001815 · Cited by 35
Immunogenicity of Bioproducts: Cellular Models to Evaluate the Impact of Therapeutic Antibody Aggregates
Nabhan, M., Pallardy, M. J., & Turbica, I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00725 · Cited by 35
Hypoxic Melanoma Cells Deliver microRNAs to Dendritic Cells and Cytotoxic T Lymphocytes through Connexin-43 Channels
Tittarelli, A., Navarrete, M., Lizana, M., Hofmann-Vega, F., & Salazar‐Onfray, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207567 · Cited by 35
Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Hsieh, R. W., Borson, S., Tsagianni, A., & Zandberg, D. P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.705614 · Cited by 35
The Interplay Between Epigenetic Regulation and CD8+ T Cell Differentiation/Exhaustion for T Cell Immunotherapy
Wong, W., Yin, B., Lam, C. Y. K., Huang, Y., Yan, J., Tan, Z., & Wong, S. H. D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.783227 · Cited by 35
Targeting CD8+ T cells with natural products for tumor therapy: Revealing insights into the mechanisms.
Wang, Y.-K., Zeng, Y., Yang, W.-Y., Wang, X., & Jiang, J.-W. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155608 · Cited by 36
Cardiopulmonary bypass and VA-ECMO induced immune dysfunction: common features and differences, a narrative review
Lesouhaitier, M., Belicard, F., & Tadié, J. (2024) · Critical Care · doi:10.1186/s13054-024-05058-z · Cited by 34
“PD1 has been widely studied in the cancer field is known to promotes T-cell exhaustion [95].”
Background
Allogeneic T cell responses are regulated by a specific miRNA-mRNA network
Sun, Y., Tawara, I., Zhao, M., Qin, Z. S., Toubai, T., Mathewson, N. D., Tamaki, H., Nieves, E. C., Chinnaiyan, A. M., & Reddy, P. R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70013 · Cited by 34
Are Microglial Cells the Regulators of Lymphocyte Responses in the CNS?
Almolda, B., González, B., & Castellano, B. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00440 · Cited by 34
Advancing targeted co-stimulation with antibody-fusion proteins by introducing TNF superfamily members in a single-chain format
Fellermeier, S., Beha, N., Meyer, J.-E., Ring, S., Bader, S., Kontermann, R. E., & Müller, D. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1238540 · Cited by 34
CD24: A Rheostat That Modulates Cell Surface Receptor Signaling of Diverse Receptors
Ayre, D. C., & Christian, S. L. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00146 · Cited by 34
Unusual CD4+CD28−T Cells and Their Pathogenic Role in Chronic Inflammatory Disorders
Lee, G. H., & Lee, W. (2016) · Immune Network · doi:10.4110/in.2016.16.6.322 · Cited by 35
Inmunoterapia y terapia génica como nuevos tratamientos contra el cáncer
Rangel‐Sosa, M. M., Aguilar-Córdova, E., & Rojas‐Martínez, A. (2017) · Colombia medica · doi:10.25100/cm.v48i3.2997 · Cited by 37
New developments in immunotherapy for lymphoma
Heyman, B. M., & Yiping, Y. (2018) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2018.0037 · Cited by 33
Importance of Feedback and Feedforward Loops to Adaptive Immune Response Modeling
Rahman, A., Tiwari, A., Narula, J., & Hickling, T. P. (2018) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12352 · Cited by 39
Isolation of B-cells using Miltenyi MACS bead isolation kits
Moore, D. K., Motaung, B., du Plessis, N., Shabangu, A., & Loxton, A. G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213832 · Cited by 34
Immune checkpoint inhibitors for small cell lung cancer: opportunities and challenges
Regzedmaa, O., Zhang, H., Liu, H., & Chen, J. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s204577 · Cited by 34
Induction of antitumor immunity in mice by the combination of nanoparticle-based photothermolysis and anti-PD-1 checkpoint inhibition
Cao, Q., Wang, W., Zhou, M., Huang, Q., Wen, X., Zhao, J., Shi, S., Ku, G., Li, F., Hatakeyama, H., et al. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102169 · Cited by 34
Combination blockade of OX40L and CD30L inhibits allergen-driven memory TH2 cell reactivity and lung inflammation
Gracias, D. T., Sethi, G. S., Mehta, A. K., Miki, H., Gupta, R. K., Yagita∥, H., & Croft, M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.037 · Cited by 34
Robust T cell activation requires an eIF3-driven burst in T cell receptor translation
Silva, D. D., Ferguson, L., Chin, G. H., Smith, B. E., Apathy, R., Roth, T. L., Blaeschke, F., Kudla, M., Marson, A., Ingolia, N. T., et al. (2021) · eLife · doi:10.7554/elife.74272 · Cited by 32
Interleukin-4 Inhibits Regulatory T Cell Differentiation through Regulating CD103+ Dendritic Cells
Tu, L., Chen, J., Zhang, H., & Duan, L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00214 · Cited by 37
Functional optimization of agonistic antibodies to OX40 receptor with novel Fc mutations to promote antibody multimerization
Zhang, D., Armstrong, A. A., Tam, S. H., McCarthy, S. G., Luo, J., Gilliland, G. L., & Chiu, M. L. (2017) · mAbs · doi:10.1080/19420862.2017.1358838 · Cited by 35
Chitosan Microsphere Used as an Effective System to Deliver a Linked Antigenic Peptides Vaccine Protect Mice Against Acute and Chronic Toxoplasmosis
Guo, J., Sun, X., Yin, H., Wang, T., Li, Y., Zhou, C., Zhou, H., He, S., & Cong, H. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00163 · Cited by 35
3D chromatin reprogramming primes human memory T H 2 cells for rapid recall and pathogenic dysfunction
Schoonhoven, A. O.-V., de Bruijn, M. J. W., Stikker, B., Brouwer, R. W. W., Braunstahl, G., van IJcken, W. F. J., Graf, T., Huylebroeck, D., Hendriks, R. W., Stik, G., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.adg3917 · Cited by 35
Impact of Immunity on Coronary Artery Disease: An Updated Pathogenic Interplay and Potential Therapeutic Strategies
Laera, N., Malerba, P., Vacanti, G., Nardin, S., Pagnesi, M., & Nardin, M. (2023) · Life · doi:10.3390/life13112128 · Cited by 34
“…proteins also have a pivotal role in mediating interactions between immune cells and non-immune cells, and these interplays regulate different pathways, such as secretion of cytokines and chemokines, cellular survival, and proliferation, thus collectively shaping the inﬂammatory response [242].”
Background
Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases
Lippert, A. H., Paluch, C., Gaglioni, M., Vuong, M. T., McColl, J. T., Jenkins, E. M., Fellermeyer, M., Clarke, J., Sharma, S., da Silva, S. M., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.01.007 · Cited by 35
Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells
Fan, D., Li, W., Yang, Y., Zhang, X., Zhang, Q., Yan, Y., Yang, M., Wang, J., & Xiong, D. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0205-6 · Cited by 33
SOCS3 Deletion in T Lymphocytes Suppresses Development of Chronic Ocular Inflammation via Upregulation of CTLA-4 and Expansion of Regulatory T Cells
Yu, C., Kim, S.-H., Mahdi, R. M., & Egwuagu, C. E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301132 · Cited by 33
Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis
Hartwell, B. L., Pickens, C. J., Leon, M. A., & Berkland, C. J. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00335 · Cited by 33
Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure
Clutton, G., & Jones, R. B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01452 · Cited by 34
Next Generation Cancer Vaccines—Make It Personal!
Terbuch, A., & Lopez, J. S. (2018) · Vaccines · doi:10.3390/vaccines6030052 · Cited by 33
Quantum Molecular Dynamics, Topological, Group Theoretical and Graph Theoretical Studies of Protein-Protein Interactions
Balasubramanian, K., & Gupta, S. P. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190304152704 · Cited by 33

Authors: Chen, L., & Flies, D. B.
Affiliations: Yale Cancer Center (US)
University of New Mexico (US)
Corresponding author: Chen, Lieping
ORCID: Chen, Lieping
Flies, Dallas B.
Venue: Nature Reviews Immunology
Publisher: Springer Science and Business Media LLC
Published: 2013-03-08
Volume: 13
Issue: 4
Pages: 227-242
ISSN: 1474-1733 (ISSN-L)
1474-1741
DOI: 10.1038/nri3405
PMC: PMC3786574
OpenAlex: W2130473166
Cited by: 3,114
References: 135
Citations by year: 2026: 148 · 2025: 258 · 2024: 259 · 2023: 276 · 2022: 305 · 2021: 312 · 2020: 310 · 2019: 250 · 2018: 275 · 2017: 238 · 2016: 195 · 2015: 148 · 2014: 101 · 2013: 35
FWCI: 13.52
Type: journal article
Language: en
Update notices: erratum (2013-06-05)
Open access: green
europepmc.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Immunology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Melanoma Research Alliance
National Cancer Institute (CA 97085, CA 16359, CA121974, CA86721, R01CA097085, CA142779, R01CA085721, R01CA142779, P50CA121974, P30CA016359)
National Institute of Allergy and Infectious Diseases (T32AI089704, R01AI072592, AI72592, T32AI007247)
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords: T cell costimulation, T cell co-inhibition, costimulatory receptors, co-inhibitory receptors, T cell receptor signaling, T cell activation, T cell differentiation, immune checkpoint molecules
MeSH terms: Humans, Lymphocyte Activation, Receptors, Antigen, T-Cell, T-Lymphocytes, Signal Transduction, CD28 Antigens, B7-1 Antigen, Models, Immunological, B7-2 Antigen, Receptors, Tumor Necrosis Factor, Member 14

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular mechanisms of T cell co-stimulation and co-inhibition

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks